Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis

Yu-Chen Huang, Ying Chih Cheng

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background The relationship between isotretinoin treatment for acne and depression is controversial. Quantitative analysis has not yet been conducted. Objective To conduct a meta-analysis, evidence-based examination of the relationship between isotretinoin and depression. Method A systematic review and meta-analysis of the literature published from inception to September 30, 2016, was conducted. Controlled or prospective non-controlled trials on ≥15 acne patients receiving isotretinoin treatment were included. The prevalence of depression and change in depression scores were calculated. Result Thirty-one studies met the inclusion criteria. In the controlled studies, the change in depression scores from baseline was not significantly different between patients receiving isotretinoin treatment and those receiving an alternative treatment (standardized mean difference [SMD] −0.334, 95% confidence interval [CI] −0.680 to 0.011). The prevalence of depression after isotretinoin treatment significantly declined (relative risk [RR] 0.588, 95% CI 0.382–0.904). The mean depression scores significantly decreased from baseline (SMD −0.335, 95% CI −0.498 to −0.172). Limitations No randomized controlled trials were reviewed; a large inter-study variation was observed. Conclusions Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.

Original languageEnglish
Pages (from-to)1068-1076.e9
JournalJournal of the American Academy of Dermatology
Volume76
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Isotretinoin
Acne Vulgaris
Meta-Analysis
Depression
Therapeutics
Confidence Intervals
Randomized Controlled Trials

Keywords

  • acne
  • depression
  • isotretinoin
  • meta-analysis
  • psychological impact
  • systemic review

ASJC Scopus subject areas

  • Dermatology

Cite this

Isotretinoin treatment for acne and risk of depression : A systematic review and meta-analysis. / Huang, Yu-Chen; Cheng, Ying Chih.

In: Journal of the American Academy of Dermatology, Vol. 76, No. 6, 01.06.2017, p. 1068-1076.e9.

Research output: Contribution to journalArticle

@article{20ac33abaedb4c219c98b094599363cc,
title = "Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis",
abstract = "Background The relationship between isotretinoin treatment for acne and depression is controversial. Quantitative analysis has not yet been conducted. Objective To conduct a meta-analysis, evidence-based examination of the relationship between isotretinoin and depression. Method A systematic review and meta-analysis of the literature published from inception to September 30, 2016, was conducted. Controlled or prospective non-controlled trials on ≥15 acne patients receiving isotretinoin treatment were included. The prevalence of depression and change in depression scores were calculated. Result Thirty-one studies met the inclusion criteria. In the controlled studies, the change in depression scores from baseline was not significantly different between patients receiving isotretinoin treatment and those receiving an alternative treatment (standardized mean difference [SMD] −0.334, 95{\%} confidence interval [CI] −0.680 to 0.011). The prevalence of depression after isotretinoin treatment significantly declined (relative risk [RR] 0.588, 95{\%} CI 0.382–0.904). The mean depression scores significantly decreased from baseline (SMD −0.335, 95{\%} CI −0.498 to −0.172). Limitations No randomized controlled trials were reviewed; a large inter-study variation was observed. Conclusions Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.",
keywords = "acne, depression, isotretinoin, meta-analysis, psychological impact, systemic review",
author = "Yu-Chen Huang and Cheng, {Ying Chih}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.jaad.2016.12.028",
language = "English",
volume = "76",
pages = "1068--1076.e9",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Isotretinoin treatment for acne and risk of depression

T2 - A systematic review and meta-analysis

AU - Huang, Yu-Chen

AU - Cheng, Ying Chih

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background The relationship between isotretinoin treatment for acne and depression is controversial. Quantitative analysis has not yet been conducted. Objective To conduct a meta-analysis, evidence-based examination of the relationship between isotretinoin and depression. Method A systematic review and meta-analysis of the literature published from inception to September 30, 2016, was conducted. Controlled or prospective non-controlled trials on ≥15 acne patients receiving isotretinoin treatment were included. The prevalence of depression and change in depression scores were calculated. Result Thirty-one studies met the inclusion criteria. In the controlled studies, the change in depression scores from baseline was not significantly different between patients receiving isotretinoin treatment and those receiving an alternative treatment (standardized mean difference [SMD] −0.334, 95% confidence interval [CI] −0.680 to 0.011). The prevalence of depression after isotretinoin treatment significantly declined (relative risk [RR] 0.588, 95% CI 0.382–0.904). The mean depression scores significantly decreased from baseline (SMD −0.335, 95% CI −0.498 to −0.172). Limitations No randomized controlled trials were reviewed; a large inter-study variation was observed. Conclusions Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.

AB - Background The relationship between isotretinoin treatment for acne and depression is controversial. Quantitative analysis has not yet been conducted. Objective To conduct a meta-analysis, evidence-based examination of the relationship between isotretinoin and depression. Method A systematic review and meta-analysis of the literature published from inception to September 30, 2016, was conducted. Controlled or prospective non-controlled trials on ≥15 acne patients receiving isotretinoin treatment were included. The prevalence of depression and change in depression scores were calculated. Result Thirty-one studies met the inclusion criteria. In the controlled studies, the change in depression scores from baseline was not significantly different between patients receiving isotretinoin treatment and those receiving an alternative treatment (standardized mean difference [SMD] −0.334, 95% confidence interval [CI] −0.680 to 0.011). The prevalence of depression after isotretinoin treatment significantly declined (relative risk [RR] 0.588, 95% CI 0.382–0.904). The mean depression scores significantly decreased from baseline (SMD −0.335, 95% CI −0.498 to −0.172). Limitations No randomized controlled trials were reviewed; a large inter-study variation was observed. Conclusions Isotretinoin treatment for acne does not appear to be associated with an increased risk for depression. Moreover, the treatment of acne appears to ameliorate depressive symptoms.

KW - acne

KW - depression

KW - isotretinoin

KW - meta-analysis

KW - psychological impact

KW - systemic review

UR - http://www.scopus.com/inward/record.url?scp=85014779960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014779960&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2016.12.028

DO - 10.1016/j.jaad.2016.12.028

M3 - Article

C2 - 28291553

AN - SCOPUS:85014779960

VL - 76

SP - 1068-1076.e9

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -